Renovia, a digital therapeutics maker for female pelvic floor disorders, today shared the closing of its Series C-1 financing round worth $17 million.
The round included previous backers including Perceptive Life Sciences, Longwood Fund, Ascension Ventures and OSF Ventures, in addition to new investor Parian Global Management.
WHAT THEY DO
Renovia's flagship product, leva, is an FDA-cleared...
